Literature DB >> 20032193

Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions.

Brent J Ryckman1, Marie C Chase, David C Johnson.   

Abstract

Human cytomegalovirus (HCMV) produces the following two gH/gL complexes: gH/gL/gO and gH/gL/UL128-131. Entry into epithelial and endothelial cells requires gH/gL/UL128-131, and we have provided evidence that gH/gL/UL128-131 binds saturable epithelial cell receptors to mediate entry. HCMV does not require gH/gL/UL128-131 to enter fibroblasts, and laboratory adaptation to fibroblasts results in mutations in the UL128-131 genes, abolishing infection of epithelial and endothelial cells. HCMV gO-null mutants produce very small plaques on fibroblasts yet can spread on endothelial cells. Thus, one prevailing model suggests that gH/gL/gO mediates infection of fibroblasts, while gH/gL/UL128-131 mediates entry into epithelial/endothelial cells. Most biochemical studies of gO have involved the HCMV lab strain AD169, which does not assemble gH/gL/UL128-131 complexes. We examined gO produced by the low-passage clinical HCMV strain TR. Surprisingly, TR gO was not detected in purified extracellular virus particles. In TR-infected cells, gO remained sensitive to endoglycosidase H, suggesting that the protein was not exported from the endoplasmic reticulum (ER). However, TR gO interacted with gH/gL in the ER and promoted export of gH/gL from the ER to the Golgi apparatus. Pulse-chase experiments showed that a fraction of gO remained bound to gH/gL for relatively long periods, but gO eventually dissociated or was degraded and was not found in extracellular virions or secreted from cells. The accompanying report by P. T. Wille et al. (J. Virol., 84:2585-2596, 2010) showed that a TR gO-null mutant failed to incorporate gH/gL into virions and that the mutant was unable to enter fibroblasts and epithelial and endothelial cells. We concluded that gO acts as a molecular chaperone, increasing gH/gL ER export and incorporation into virions. It appears that gO competes with UL128-131 for binding onto gH/gL but is released from gH/gL, so that gH/gL (lacking UL128-131) is incorporated into virions. Thus, our revised model suggests that both gH/gL and gH/gL/UL128-131 are required for entry into epithelial and endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032193      PMCID: PMC2820934          DOI: 10.1128/JVI.02256-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.

Authors:  Regan N Theiler; Teresa Compton
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

3.  Reevaluation of human cytomegalovirus coding potential.

Authors:  Eain Murphy; Isidore Rigoutsos; Tetsuo Shibuya; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

4.  Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II.

Authors:  M Homman-Loudiyi; K Hultenby; W Britt; C Söderberg-Nauclér
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Herpes simplex virus with highly reduced gD levels can efficiently enter and spread between human keratinocytes.

Authors:  M T Huber; T W Wisner; N R Hegde; K A Goldsmith; D A Rauch; R J Roller; C Krummenacher; R J Eisenberg; G H Cohen; D C Johnson
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 6.  The human cytomegalovirus.

Authors:  Santo Landolfo; Marisa Gariglio; Giorgio Gribaudo; David Lembo
Journal:  Pharmacol Ther       Date:  2003-06       Impact factor: 12.310

7.  Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.

Authors:  Nagendra R Hegde; Roman A Tomazin; Todd W Wisner; Claire Dunn; Jessica M Boname; David M Lewinsohn; David C Johnson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  Expression and reconstitution of the gH/gL/gO complex of human cytomegalovirus.

Authors:  Eric R Kinzler; Regan N Theiler; Teresa Compton
Journal:  J Clin Virol       Date:  2002-08       Impact factor: 3.168

9.  Two novel spliced genes in human cytomegalovirus.

Authors:  Parvis Akter; Charles Cunningham; Brian P McSharry; Aidan Dolan; Clare Addison; Derrick J Dargan; Aycan F Hassan-Walker; Vincent C Emery; Paul D Griffiths; Gavin W G Wilkinson; Andrew J Davison
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

10.  The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics.

Authors:  Gabriele Hahn; Hanna Khan; Fausto Baldanti; Ulrich H Koszinowski; M Grazia Revello; Giuseppe Gerna
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more
  35 in total

1.  Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.

Authors:  Akiko Kawabata; Hiroko Oyaizu; Takahiro Maeki; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells.

Authors:  Adam L Vanarsdall; Marie C Chase; David C Johnson
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.

Authors:  Frances M Saccoccio; Anne L Sauer; Xiaohong Cui; Amy E Armstrong; El-Sayed E Habib; David C Johnson; Brent J Ryckman; Aloysius J Klingelhutz; Stuart P Adler; Michael A McVoy
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

Review 4.  Human cytomegalovirus entry into cells.

Authors:  Adam L Vanarsdall; David C Johnson
Journal:  Curr Opin Virol       Date:  2012-01-30       Impact factor: 7.090

5.  Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope.

Authors:  Momei Zhou; Qin Yu; Anya Wechsler; Brent J Ryckman
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

Review 6.  Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.

Authors:  Thomas J Gardner; Domenico Tortorella
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

7.  Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes.

Authors:  John W Loughney; Richard R Rustandi; Dai Wang; Matthew C Troutman; Lawrence W Dick; Guanghua Li; Zhong Liu; Fengsheng Li; Daniel C Freed; Colleen E Price; Van M Hoang; Timothy D Culp; Pete A DePhillips; Tong-Ming Fu; Sha Ha
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

8.  The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV.

Authors:  Laura Scrivano; Jasmina Esterlechner; Hermine Mühlbach; Nicole Ettischer; Christoph Hagen; Kay Grünewald; Christian A Mohr; Zsolt Ruzsics; Ulrich Koszinowski; Barbara Adler
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

9.  Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Erin E Ellerbeck; Brent J Ryckman
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

10.  A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.

Authors:  Felix Wussow; Yujuan Yue; Joy Martinez; Jesse D Deere; Jeff Longmate; Andreas Herrmann; Peter A Barry; Don J Diamond
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.